Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen sales Fleet Crash Rate (Crashes per Million Miles — CPMM, legacy) (rate) (×)
Amgen Sustainability Report
Latest, FY2023
2.27
Period ended Dec 31, 2023
Change on a year earlier
-2.2%
2.32 in FY2022
History
5 years
Since FY2019
Sources
1
https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Sales Fleet Crash Rate (Crashes per Million Miles — CPMM, legacy) (rate) (×) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 2.27 | -2.2% | https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf ↗ |
| FY2022 | Dec 31, 2022 | 2.32 | -2.9% | https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf ↗ |
| FY2021 | Dec 31, 2021 | 2.39 | -29.3% | https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf ↗ |
| FY2020 | Dec 31, 2020 | 3.38 | -23.2% | https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf ↗ |
| FY2019 | Dec 31, 2019 | 4.40 | – | https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf ↗ |
Cite this data
StockData. (2026). Amgen Sales Fleet Crash Rate (Crashes per Million Miles — CPMM, legacy) (rate) (×), annual FY2019–FY2023 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/esg_fleet_cpmm
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.